Correlation Between NOL Index After Stimulus and Post-operative Opioid, Pain, Pre-operative Phenotype

Sponsor
Ciusss de L'Est de l'Île de Montréal (Other)
Overall Status
Recruiting
CT.gov ID
NCT03422783
Collaborator
(none)
69
1
1
58.5
1.2

Study Details

Study Description

Brief Summary

This study evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS).

Condition or Disease Intervention/Treatment Phase
  • Device: Standardized tetanic stimulation
  • Diagnostic Test: Catastrophizing score
  • Diagnostic Test: Nociceptive threshold
  • Biological: Biomarkers
N/A

Detailed Description

The NoL index, a nociception monitor using a multiparametric approach, has shown an excellent sensitivity and specificity in detecting noxious stimuli under general anesthesia. This monitor is better than any other parameter in grading nociception under general anesthesia. More recently, it has recently been shown a strong correlation between NoL index response to nociceptive stimulus and the level of opioid analgesia during surgery. No study has evaluated that NoL could predict post-operative pain so far. It has not yet been proven that NoL was correlated with post-operative opioid consumption or with post-operative pain scores.

Some phenotypic factors were previously shown to correlate with post-operative pain and opioid consumption, such as psychological factors and tests, or also assessment of some pre-operative nociceptive thresholds (NT). Pain catastrophizing was proven in several studies to correlate with acute post-operative pain.

So far, no study compared each of these preoperative psychological factors or nociceptif thresholds to the NoL index response to intraoperative standardized pain stimulus in terms of correlation with post-operative opioid requirements and pain scores.

Moreover, there is no study evaluating the pro-inflammatory protein profiles that might likely be correlated to inter-individual differences in NoL response after this standardized nociceptive stimulus under general anesthesia.

This study will assess the level of correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS). It also evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and pre-operative phenotype and post-operative pain biomarkers.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
69 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective Pilot studyProspective Pilot study
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Correlation Between NoL Index Response to Standardized Stimulus Under General Anesthesia and: Post-operative Opioid Consumption and Pain, Pre-operative Phenotype and Pain Biomarkers
Actual Study Start Date :
Jan 15, 2018
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Included patients

There is only one arm in this study. Intervention will be electrical forearm stimulus under general anesthesia and the response of NOL index following this stimulus and its correlation with postoperative parameters such as pain and opioid consumption in post anesthesia care unit.

Device: Standardized tetanic stimulation
The "intervention" is not a drug, but it is standardized electrical stimulus applied with a muscle relaxation monitor on the forearm of the anesthetized patient. The NoL index is registered in response to this stimulus in an observational manner. Device: Device PMD200TM offering intraoperative NoL Index

Diagnostic Test: Catastrophizing score
Pre-operative catastrophizing score is correlated with post-operative pain and opioid consumption

Diagnostic Test: Nociceptive threshold
Nociceptive threshold for pressure, heat and electrical stimulation are associated with post-operative pain and will be assessed preoperatively to see if there is correlation between them and the NOL index response to the nociceptive stimulus (see intervention 1)

Biological: Biomarkers
Some biomarkers of inflammation and endogenous opioids are associated with post-operative pain. Blood samples will be withdrawn at D0 before surgery starts, D1 (H24) and D2 (H48) after surgery to see if they correlate with NOL changes after the stimulus described in intervention 1 above

Outcome Measures

Primary Outcome Measures

  1. Correlation between NoL index and Hydromorphone consumption H24 [Day 1 at 24 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Total hydromorphone consumption (PACU and PCA) 24h after surgery

Secondary Outcome Measures

  1. Pain scores (NRS) in PACU from 0 to 10 [Day 0 at hour 2]

    Pain scores from 0 to 10 after surgery, using numerical rating scale in post anesthesiology care unit

  2. Correlation between NoL index and Pain scores (NRS from 0 to 10) in PACU [Day 0 at hour 2]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores after surgery, in post anesthesiology care unit

  3. Pain scores (NRS from 0 to 10) at H24 at rest [Day 1 at 24 hours]

    Pain scores (NRS from 0 to 10) at H24 at rest

  4. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 at rest [Day 1 at 24 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H24 at rest

  5. Pain scores (NRS) at H24 while coughing from 0 to 10 [Day 1 at 24 hours]

    Pain scores (NRS) at H24 while coughing from 0 to 10

  6. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 while coughing [Day 1 at 24 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H24 while coughing

  7. Pain scores (NRS) at H48 at rest from 0 to 10 [Day 2 at 48 hours]

    Pain scores (NRS) at H48 at rest from 0 to 10

  8. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H48 at rest [Day 2 at 48 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H48 at rest

  9. Pain scores (NRS) at H48 while coughing from 0 to 10 [Day 2 at 48 hours]

    Pain scores (NRS) at H48 while coughing from 0 to 10

  10. Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H48 while coughing [Day 2 at 48 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Pain scores (NRS) at H48 while coughing

  11. total hydromorphone consumption (mg) in PACU [Day 0 at 2 hours]

    general anesthesia and total hydromorphone consumption (mg) in PACU

  12. Correlation between NoL index and total hydromorphone consumption (mg) in PACU [Day 0 at 2 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and total hydromorphone consumption (mg) in PACU

  13. Total hydromorphone consumption (mg) at H48 [Day 2 at 48 hours]

    Total hydromorphone consumption (mg) at H48

  14. Correlation between NoL index and total hydromorphone consumption (mg) at H48 [Day 2 at 48 hours]

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and total hydromorphone consumption (mg) at H48

  15. Pain catastrophizing scale from 0 to 50 (fully validated and published questionnaire) [Pre-operative, 2 hours prior to surgery]

    Pain catastrophizing scale from 0 to 50

  16. Correlation between Pain catastrophizing scale from 0 to 50 and Total (hydromorphone consumption at day 1 24 hours) [Day 1 at 24 hours]

    Correlation between Pain catastrophizing scale and Total hydromorphone

  17. Correlation between Pain catastrophizing scale from 0 to 50 and NoL index [Day 0]

    Correlation between pre-operative Pain catastrophizing scale and NoL index absolute values after electrical stimulus under general anesthesia

  18. State-Trait anxiety Inventory from 0 to 80 (fully validated and published questionnaire) [Day 0]

    State-Trait anxiety Inventory from 0 to 80

  19. Correlation between State-Trait anxiety Inventory questionnaire from 0 to 80 and NoL index [Day 0]

    Correlation between pre-operative State-Trait anxiety Inventory and NoL index absolute values after electrical stimulus under general anesthesia

  20. Correlation between State-Trait anxiety Inventory from 0 to 80 and Total hydromorphone consumption at H24 [Day 1 24 hours]

    Correlation between State-Trait anxiety Inventory and Total hydromorphone consumption at H24

  21. mechanic pain threshold [Pre-operative, 2 hours prior to surgery]

    mechanic pain threshold using electronic Von Frey

  22. thermal pain threshold [Pre-operative, 2 hours prior to surgery]

    thermal pain threshold using Qsense device

  23. electrical pain threshold [Pre-operative, 2 hours prior to surgery]

    electrical pain threshold using Pain Matcher device

  24. Biomarkers level Pre-op [Pre-operative, H0 right after induction of general anesthesia]

    Biomarkers level Pre-op

  25. Biomarkers level H24 [Day 1 24 hours]

    Biomarkers level H24

  26. Biomarkers level H48 [Day 2 48 hours]

    Biomarkers level H48

  27. Brief Pain inventory (3M) Questionnaire (validated and published questionnaire) [3 months]

    Brief Pain inventory (3M)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patient (Age 18 or older)

  • ASA status I, II or III

  • elective video assisted thoracoscopy under general anesthesia

Exclusion Criteria:
  • history of coronary artery disease

  • serious cardiac arrhythmia (including atrial fibrillation),

  • history of substance abuse,

  • chronic use of psychotropic and/or opioid drugs,

  • use of drugs that act on the autonomic nervous system (including β-blockers),

  • history of psychiatric diseases,

  • allergy to any drug used in the study protocol,

  • refusal of the patient

  • unexpected difficult airway requesting excessive, possibly painful airway manipulations

  • unexpected intraoperative complications requiring strong hemodynamic support (transfusions, vasopressors, inotropes)

  • conversion to thoracotomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal Montréal-Est Quebec Canada H1T2M4

Sponsors and Collaborators

  • Ciusss de L'Est de l'Île de Montréal

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Philippe Richebe, Director of Research in the Department of Anesthesiology, Ciusss de L'Est de l'Île de Montréal
ClinicalTrials.gov Identifier:
NCT03422783
Other Study ID Numbers:
  • Ciusss
First Posted:
Feb 6, 2018
Last Update Posted:
Oct 4, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Philippe Richebe, Director of Research in the Department of Anesthesiology, Ciusss de L'Est de l'Île de Montréal
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2021